医学
无症状的
肺动脉高压
内科学
心脏病学
入射(几何)
外科
群(周期表)
突变
肺动脉
基因检测
儿科
人口
呼吸道疾病
作者
Julia Rodighiero,Joshua Durbin,Lauren Badalato,Stephen L. Archer
出处
期刊:CJC open
[Elsevier BV]
日期:2026-05-01
卷期号:8 (8): 1060-1063
标识
DOI:10.1016/j.cjco.2026.04.013
摘要
Pulmonary arterial hypertension (PAH) is defined by mean pulmonary artery pressure (mPAP) > 20 mm Hg and pulmonary vascular resistance (PVR) > 2 Wood Units (WU), without significant left heart, lung, or chronic thromboembolic disease. Diagnosis of symptomatic PAH is often delayed, which increases morbidity and mortality.1 Genetic testing allows early identification of “at-risk” individuals, but raises questions about the timing of hemodynamic assessment and initiation of therapy. We report a family in which genetic testing revealed an autosomal dominant KCNK3 variant leading to identification of 2 asymptomatic relatives with mild PAH.
科研通智能强力驱动
Strongly Powered by AbleSci AI